Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Arthritis, Rheumatoid × Etanercept × Clear all

Phase

Status

Completed 8 Unknown 4 Withdrawn 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Stomatitis 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Inflammation 1 Fatigue Syndrome, Chronic 1 Bone Neoplasms 1 Bites and Stings 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 4 veltuzumab 1 tocilizumab 1 andecaliximab 1 Tumor Necrosis Factor Inhibitors 1 RC-18 1 Nivolumab 1 Interleukin 1 Receptor Antagonist Protein 1 Folic Acid 1 Etanercept 1 Bortezomib 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02109289 2017-02-07

Etanercept in Rheumatoid Arthritis and Vascular Inflammation

Innovaderm Research Inc.

Phase 4 Terminated

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡